XML 161 R105.htm IDEA: XBRL DOCUMENT
v3.26.1

Offerings | Jul. 21, 2026 USD ($) shares
--- | ---
Offering: 1 |
Offering: |
Fee Previously Paid | false
Other Rule | true
Security Type | Equity
Security Class Title | Common Stock, par value $0.0001 per share
Amount Registered | shares | 42,605,021
Maximum Aggregate Offering Price | $ 8,190.12
Fee Rate | 0.01381%
Amount of Registration Fee | $ 1.14
Offering Note |
(1) | (a) | Represents the maximum number of shares of Common Stock, par value $0.0001 per share (“Passage Bio Common Stock”), of Passage Bio, Inc. (“Passage Bio”), that are expected to be issued (or become issuable) to securityholders of Remix Therapeutics, Inc. (“Remix”) pursuant to the merger and related transactions contemplated by the Agreement and Plan of Merger, dated as of June 24, 2026 (“Merger Agreement”), by and among Passage Bio, Merger Sub, Inc., and Remix, with Remix continuing as a wholly-owned subsidiary of Passage Bio and the surviving corporation of the merger. The number of shares of Passage Bio Common Stock to be registered on this registration statement (“Registration Statement”) consists of (i) the estimated number of shares of Passage Bio Common Stock that are expected to be issued in exchange for shares of Remix Common Stock (the “Remix Common Stock”) outstanding immediately prior to the Effective Time (as defined in the Merger Agreement), including the shares of Remix Common Stock to be issued in the PIPE Financing, after giving effect to (A) the conversion of all outstanding shares of Remix preferred stock into shares of Remix Common Stock, (B) the conversion of the 2025 Convertible Notes (as defined in the Registration Statement) and the associated warrants into shares of Remix Common Stock, and (C) the conversion of the 2026 Convertible Notes into shares of Remix Common Stock, each without taking into account the effect of a reverse stock split of Passage Bio Common Stock and assuming a maximum pre-split exchange ratio of approximately 0.1734 shares of Passage Bio Common Stock for each outstanding share of Remix Common Stock (which is subject to adjustment prior to the closing of the Merger), and (ii) shares of Passage Bio Common Stock issuable upon exercise of warrants issued in the merger in exchange for Remix warrants, without taking into account the effect of a reverse stock split of Passage Bio Common Stock and assuming a maximum pre-split exchange ratio of approximately 0.1734 shares of Passage Bio Common Stock for each outstanding share of Remix Common Stock (which is subject to adjustment prior to the closing of the Merger), and (iii) options to purchase shares of Passage Bio Common Stock in exchange for options to purchase shares of Remix Common Stock outstanding under the Remix 2019 Plan, without taking into account the effect of a reverse stock split of Passage Bio Common Stock and assuming a maximum pre-split exchange ratio of approximately 0.1734 shares of Passage Bio Common Stock for each outstanding share of Remix Common Stock (which is subject to adjustment prior to the closing of the Merger).
| (b) | Estimated solely for the purpose of calculating the registration fee under Rule 457(f)(2) under the Securities Act of 1933, as amended. Remix is a private company, no market exists for its securities, and Remix has an accumulated capital deficit. Therefore, the proposed maximum aggregate offering price is calculated based on an aggregate offering amount equal to one-third of the aggregate par value of the Remix Common Stock that will be exchanged in the merger.
| (c) | In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any securities that may from time to time be offered or issued resulting from forward or reverse stock splits, stock dividends or similar transactions.
Offering: 2 |
Offering: |
Fee Previously Paid | false
Other Rule | true
Security Type | Equity
Security Class Title | Warrants to purchase Common Stock
Amount Registered | shares | 24,891
Amount of Registration Fee | $ 0
Offering Note |
(2) | Consists of Passage Bio warrants issued in the merger in exchange for Remix warrants, without taking into account the effect of a reverse stock split of Passage Bio Common Stock and assuming a maximum pre-split exchange ratio of approximately 0.1734 shares of Passage Bio Common Stock for each outstanding share of Remix Common Stock (which is subject to adjustment prior to the closing of the Merger). The registration fee with respect to the warrants has been allocated to the underlying shares of Passage Bio Common Stock issuable upon exercise of such Passage Bio warrants, as described in footnote (1).
Offering: 3 |
Offering: |
Fee Previously Paid | false
Other Rule | true
Security Type | Equity
Security Class Title | Options to purchase Common Stock
Amount Registered | shares | 3,058,476
Amount of Registration Fee | $ 0
Offering Note |
(3) | Consists of Passage Bio stock options to purchase shares of Passage Bio Common Stock issued in exchange for Remix stock options to purchase shares of Remix Common Stock, without taking into account the effect of a reverse stock split of Passage Bio Common Stock and assuming a maximum pre-split exchange ratio of approximately 0.1734 shares of Passage Bio Common Stock for each outstanding share of Remix Common Stock (which is subject to adjustment prior to the closing of the Merger). The registration fee with respect to the options to purchase shares of Passage Bio Common Stock has been allocated to the underlying shares of Passage Bio Common Stock issuable upon exercise of such options, as described in footnote (1).

X
- Definition The amount of securities being registered. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 + Details
Name: | ffd_AmtSctiesRegd
Namespace Prefix: | ffd_
Data Type: | ffd:nonNegativeDecimal2ItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total amount of registration fee (amount due after offsets). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 + Details
Name: | ffd_FeeAmt
Namespace Prefix: | ffd_
Data Type: | ffd:nonNegative1TMonetary2ItemType
Balance Type: | na
Period Type: | duration

X
- Definition The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 + Details
Name: | ffd_FeeRate
Namespace Prefix: | ffd_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 + Details
Name: | ffd_FeesOthrRuleFlg
Namespace Prefix: | ffd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- Definition The maximum aggregate offering price for the offering that is being registered. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 + Details
Name: | ffd_MaxAggtOfferingPric
Namespace Prefix: | ffd_
Data Type: | ffd:nonNegative100TMonetary2ItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 + Details
Name: | ffd_OfferingNote
Namespace Prefix: | ffd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The title of the class of securities being registered (for each class being registered). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 + Details
Name: | ffd_OfferingSctyTitl
Namespace Prefix: | ffd_
Data Type: | ffd:securityTitleItemType
Balance Type: | na
Period Type: | duration

X
- Definition Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other" + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 + Details
Name: | ffd_OfferingSctyTp
Namespace Prefix: | ffd_
Data Type: | ffd:securityTypeItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ffd_OfferingTable
Namespace Prefix: | ffd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ffd_PrevslyPdFlg
Namespace Prefix: | ffd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ffd_OfferingAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ffd_OfferingAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ffd_OfferingAxis=3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |